Safety and efficacy of treatment for chronic hepatitis C with a focus on pegylated interferons: the backbone of therapy today and in the future

Author： Ferenci Peter  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.4, 2011-07, pp. : 529-544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegylated Interferons for the Treatment of Chronic Hepatitis C: Pharmacological and Clinical Differences between Peginterferon-α-2a and Peginterferon-α-2b

By Foster Graham R.  

Drugs, Vol. 70, Iss. 2, 2010-01 ,pp. : 147-165

Adis International

Access to resources Recommend Favorite

Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus

By Foster Graham R  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 685-691

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Pegylated Interferon Antiviral Therapy of Chronic Hepatitis C

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 5, Iss. 4, 2006-10 ,pp. : 379-387

Bentham Science Publishers

Access to resources Recommend Favorite

Triple therapy including histamine dihydrochloride shows efficacy in chronic hepatitis C

By  

Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Current and Future Therapy for Chronic Hepatitis C Virus Liver Disease

By  

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 3, 2003-09 ,pp. : 247-253

Bentham Science Publishers

Access to resources Recommend Favorite